Improvement of Lymphocyte Proliferation in Human Immunodeficiency Virus Infection after Recombinant Interleukin-2 Treatment

References

• Meyaard L, Otto SA, Keet IP, Van Lier RA, Miedema FA. Changes in cytokine secretion patterns of CD4 + T-cell clones in human immunodeficiency virus infection. Blood 1994; 84: 4262–8.
   Google Scholar
• Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, et al. Detection of three distinct patterns of T-helper dysfunction in asymptomatic HIV-seropositive patients: independence of CD4 + cell number and clinical staging. J Clin Invest 1989; 84: 1892–9.
   PubMed Web of Science ®Google Scholar
• Meroni L, Trabattoni D, Balotta C, Riva C, Gori A, Meroni M, et al. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS 1996; 10: 23–30.
   PubMedGoogle Scholar
• Robb RJ, Smith KA. Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol Immunol 1981; 18: 1087–94.
   PubMed Web of Science ®Google Scholar
• Smith KA. T-cell growth factor. Immunol Rev 1980; 51: 337–57.
   PubMed Web of Science ®Google Scholar
• Morgan DA, Ruscetti FW, Gallo RC. Selective in vitro growth of T-lymphocytes from normal human bone marrow. Science 1976; 193: 1007–8.
   Google Scholar
• Ciobanu N, Welte K, Kruger G, Venuta S, Gold J, Feldman P, et al. Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correlation by interleukin 2. J Clin Immunol 1983; 3: 332–40.
   PubMed Web of Science ®Google Scholar
• Hofmann B, Lindhardt BO, Gerstoft J, Petersen CS, Platz P, Ryder LP, et al. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J 1987; 295: 293–6.
   PubMed Web of Science ®Google Scholar
• Hofmann B, Jakobsen KD, 0dum N, Dickmeiss E, Platz P, Ryder LP, et al. HIV-induced immunodeficiency: relatively preserved phytohemagglutinin as opposed to decreased poke- weed mitogen responses may be due to possibly responses via CD2/phytohemagglutinin pathway. J Immonol 1989; 142: 1874–80.
   Google Scholar
• Hofmann B, Nishanian P, Nguyen T, Liu M, Fahay JL. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 1993; 7: 659–64.
   Google Scholar
• Kinter A, Fauci AS. Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement. Immunol Res 1996; 15: 1–15.
   PubMedGoogle Scholar
• Giorgi JV, Fahay JL, Smith DC, Hultin LE, Cheng HL, Mitsuyasu RT, et al. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987; 138: 3725–30.
   PubMed Web of Science ®Google Scholar
• Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, Mann DL, et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989; 339: 383–5.
   PubMed Web of Science ®Google Scholar
• Kelleher, Car A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173: 321–9.
   PubMed Web of Science ®Google Scholar
• Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, et al. Sustained increases in CD4 + T-Lymphocytes in HIV-infected patients with intermittent continuous infusion interleukin-2 therapy: a preliminary report. N Engl J Med 1995; 332: 567–75.
   PubMed Web of Science ®Google Scholar
• Nielsen SD, Nielsen JO, Hansen J-ES. In vitro separation and expansion of CD4 lymphocytes from HIV-infected individuals without activation of HIV infection. J Immunol Meth 1997; 200: 107–12.
   Google Scholar
• Afzelius P, Nielsen SD, Nielsen JO, Hansen J-ES. The serotonin analogue buspirone increases the function of PBMC from HIV-infected individuals in vitro. Scand J Infect Dis 1997; 29: 117–20.
   Google Scholar
• Lipkowitz S, Green WC, Rubin AL, Novogrodsky A, Stenzel KH. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J Immunol 1984; 132: 31–7.
   Google Scholar
• Eugen-Olsen J, Afzelius P, Andresen L, Iversen J, Kronborg G, Aabech P, et al. Serotonin modulates immune function in T-cells from HIV-seropositive subjects. Clin Immunol Im- munopathol 1997; 84: 115–21.
   PubMedGoogle Scholar
• Nielsen SD, Afzelius P, Ersbøll A, Nielsen JO, Hansen J-ES. Expression of activation antigens CD69 and CD25 predicts functionality of vitro expanded PBMC from healthy donors and HIV-infected patients. Clin Exp Immunol Clin Exp Immunol 1998; 114: 66–72.
   Google Scholar
• Siekevitz M, Josephs SF, Dukovich M, Peffer N, Wong-Staal F, Greene WC. Activation of HIV-1 LTR by T-cell mitogens and trans-activator protein of HTLV-I. Science 1987; 238: 1575–8.
   Google Scholar
• Schønning K, Nielsen C, Iversen J, Nielsen JO, Hansen J-ES. Neutralizing antibodies in slowly progressing HIV-1 infection J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 400–7.
   Google Scholar
• Grabstein K, Dower S, Gillis S, Urdal D, Larsen A. Expression of interleukin 2, Interferon-(, and the IL 2 receptor by human peripheral blood lymphocytes. J Immunol 1986; 136: 4503–8.
   Google Scholar
• Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, et al. Structure and expression of a cloned cDNA of IL-2. Nature 1983; 302: 305–10.
   PubMed Web of Science ®Google Scholar